MDD patients presented lower levels of COX-2 expression in PBMCs (Fig. 4A) compared with HC, without changes in the proinflammatory PGE2 and the anti-inflammatory 15d-PGJ2 plasma levels (Fig. 4B, C). The gene discussed is PTGS2; the disease is major depressive disorder.